Princeton Global Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Princeton Global Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$5K	Hold
2022 Q2	$4K	Hold
2022 Q1	$4K	Sell
2021 Q4	$23K	Sell
2021 Q3	$471K	Sell
2021 Q2	$738K	Buy
2021 Q1	$524K	Buy